SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
BRAINSTORM CELL
(NQBB:BCLI Last Sale: 6.57 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details


NQBB: (BCLI : $6.57)
$172,337 million Market Cap at Market Close, July 1, 2022
Biomedics SubIndustry up .00% / Health Industry up .00% Today

1350 Avenue of the Americas Research Report Earnings Snapshot - Last 11/13/18
New York, NY 10019 Fact Sheet
Phone: 212-557-9000 Financial Statements
Peer Comparison

Yaffa Beck, CEO
Developing stem cell therapeutic products based on breakthrough technologies enabling the in vitro differentiation of bone marrow stem cells to neural-like cells.
Historical Charts    Technical Analysis
No Historical Data available for BCLI

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common BCLI $6.57 $6.57 0 .0 $6.25 $6.65 489,219 $6.25 $6.65 26,230,839
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $172,336,612

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex